Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

REVIEW

The Hippo pathway: regulators and regulations

Fa-Xing Yu and Kun-Liang Guan1 Department of Pharmacology, Moores Center, University of California at San Diego, La Jolla, California 92093, USA

Control of number is crucial in development a key node to coordinate these cellular processes (Fig. 1). and tissue homeostasis, and its dysregulation may result The Hippo pathway was first defined in by in tumor formation or degeneration. The Hippo genetic mosaic screens for tumor suppressor . Ge- pathway in both Drosophila and regulates cell netic inactivation of genes, including Warts (Wts) (Justice number by modulating , cell death, and et al. 1995; Xu et al. 1995), Hippo (Hpo) (Harvey et al. 2003; cell differentiation. Recently, numerous upstream com- Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu ponents involved in the Hippo pathway have been iden- et al. 2003), Salvador (Sav;alsoknownasShar-Pei)(Kango- tified, such as cell polarity, , and Singh et al. 2002; Tapon et al. 2002), and Mats (Lai et al. G--coupled (GPCR) signaling. cyto- 2005), all resulted in a similar with robust skeleton or cellular tension appears to be the master tissue overgrowth. Yorkie (Yki) is the major downstream that integrates and transmits upstream sig- effector of the Hippo pathway (Huang et al. 2005), which nals to the core Hippo signaling cascade. Here, we review regulates a program by interacting with the regulatory mechanisms of the Hippo pathway and discuss Scalloped (Sd) (Fig. 2; Goulev et al. potential implications involved in different physiological 2008; Wu et al. 2008; Zhang et al. 2008; Zhao et al. 2008). and pathological conditions. The Hippo pathway is highly conserved in mammals: MST1/2 (Hpo orthologs), Sav1, Lats1/2 (Wts orthologs), Cell proliferation, death, and differentiation are funda- and Mob1 (MOBKL1A and MOBKL1B, Mats orthologs) mental biological processes. Coordination of these pro- form a cascade that phosphorylates and inhibits cesses is critical for a wide range of physiological and YAP/TAZ (Yki orthologs). YAP/TAZ in conjunction with pathological conditions (Pellettieri and Sanchez Alvarado TEAD1–4 (Sd orthologs) mediate major physiological 2007; Galliot and Ghila 2010). During development, an functions of the Hippo pathway (Fig. 2; for reviews, see increase in cell number is required to boost organ and Pan 2010; Zhao et al. 2010a). The nomenclature of many body size; meanwhile, proper differentiation of multiple components of the Hippo pathway in Drosophila and cell types will assure the appropriate function of devel- mammals is different, and a summary of these compo- oped organs. In adulthood, most tissues undergo contin- nents is shown in Table 1. uous cell turnover to maintain functionality. Aged or The core Hippo pathway has been well established in damaged cells are programmed to cell death, whereas both Drosophila and mammals; however, the regulatory adult stem cells may divide and differentiate to replace mechanisms for this signaling pathway are less under- those dysfunctional cells. Under pathological conditions, stood. Recently, by using both genetic and biochemical such as wound healing and organ regeneration, cell approaches, many additional components have been iden- division and differentiation of tissue-specific progenitor tified to modulate the core Hippo pathway (Table 1). In cells will be up-regulated to compensate for the lost cells. this review, we briefly describe the components of the On the other hand, uncontrolled cell proliferation and Hippo pathway and summarize recent advances with decreased cell death lead to hyperplasia or tumorigenesis. respect to Hippo pathway regulation. In addition, we also Detailed mechanisms underlying cell proliferation, cell discuss the implications of Hippo pathway regulation death, and cell differentiation have been extensively in different physiological and pathological conditions. studied; however, how these processes are coordinated The mammalian Hippo pathway is the main focus, al- and integrated is poorly understood. though some Drosophila works are also covered. For a Recently, the Hippo pathway has been shown to pro- detailed review on the Drosophila Hippo pathway, please mote cell death and differentiation and inhibit cell pro- refer to Staley and Irvine (2012). liferation; therefore, the Hippo pathway may function as Core Hippo pathway: a kinase cascade [Keywords: actin; GPCR; Hippo; YAP; mechanotransduction; polarity] MST1/2 are STE20 family protein and can phos- 1Corresponding author E-mail [email protected] phorylate Sav1, Lats1/2, and Mob1 (Wu et al. 2003; Chan Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.210773.112. et al. 2005; Callus et al. 2006; Praskova et al. 2008). The

GENES & DEVELOPMENT 27:355–371 Ó 2013 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/13; www.genesdev.org 355 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan

2007; Lei et al. 2008; Oh and Irvine 2008), in which the interaction may be mediated by PPxY motifs on Lats1/2 and WW domains on YAP/TAZ (Hao et al. 2008; Oka et al. 2008). Lats1/2 are AGC family kinases and recognize the substrate consensus sequence HXRXXS (Zhao et al. 2007). All five HXRXXS sites on YAP are directly phos- phorylated by Lats1/2 (Zhao et al. 2010b). The phosphor- ylated form of YAP is sequestered in the cytoplasm via a 14-3-3 interaction, resulting in inhibition of target transcription (Zhao et al. 2007). Also, TAZ and Yki are phosphorylated by Lats1/2 or Wts, respectively, on mul- tiple HXRXXS sites (Kanai et al. 2000; Dong et al. 2007; Lei et al. 2008; Oh and Irvine 2008; Ren et al. 2010b). In contrast, when upstream kinases are inactive, Yki/ YAP/TAZ will be hypophosphorylated and translocate into the nucleus to exert their functions on gene expres- Figure 1. Implications of the Hippo pathway in cell biology. sion (Kanai et al. 2000; Dong et al. 2007; Zhao et al. 2007; The Hippo pathway modulates cell proliferation, differentiation, Lei et al. 2008; Oh and Irvine 2008; Ren et al. 2010b). The growth, and death. The coordination of different cellular pro- status of YAP/TAZ also regulates their cesses by the Hippo pathway may contribute to diverse physio- protein stability. Phosphorylation of YAP (S381) and logical and pathological conditions such as development, tissue TAZ (S311) by Lats1/2 primes subsequent phosphoryla- homeostasis, and tumorigenesis. tion events by (CK1d/e); this sequential phosphorylation results in recruitment of b- repeat-containing (b-TRCP; a subunit of the SCF kinase activity of MST1/2 is enhanced through interaction ubiquitin E3 ligase) and consequently leads to degradation with Sav1, which is mediated by SARAH (Sav/Rassf/Hpo) of YAP/TAZ (CY Liu et al. 2010; Zhao et al. 2010b). domains present in both MST1/2 and Sav1 (Callus et al. Therefore, by affecting YAP/TAZ protein localization 2006). In addition, the thousand-and-one (TAO) amino and stability, phosphorylation by upstream kinases rep- acids kinase or TAOK1–3 has been shown to directly resents a central regulatory mechanism for YAP/TAZ phosphorylate and activate Hpo or MST1/2 (Boggiano (Fig. 2). et al. 2011; Poon et al. 2011). In Drosophila, RASSF YAP/TAZ do not contain intrinsic DNA-binding do- competes with Sav for Hpo and recruits a PP2A com- mains but instead bind to the promoters of target genes plex (dSTRIPAK) to dephosphorylate and inactivate Hpo (Polesello et al. 2006; Ribeiro et al. 2010). However, mul- tiple RASSF isoforms in mammals showed different roles on the Hippo pathway (Praskova et al. 2004; Ikeda et al. 2009), suggesting a divergent role through evolution. MST1/2 directly phosphorylate Lats1/2 at the hydro- phobic motif (Lats1 T1079 and Lats2 T1041), and this phosphorylation is required for Lats1/2 activation (Chan et al. 2005). Mob1, when phosphorylated by MST1/2, binds to the autoinhibitory motif in Lats1/2, which in turn leads to the phosphorylation of the Lats activation loop (Lats1 S909 and Lats2 S872) and thereby an increase of their kinase activity (Chan et al. 2005; Praskova et al. 2008). Sav1 may function as a bridge to bring MST1/2 and Lats1/2 together (Tapon et al. 2002; Callus et al. 2006) and may enhance or inhibit the activity of Lats1/2 upon phosphorylation by MST1/2 or salt-inducible kinases, respectively (Callus et al. 2006; Wehr et al. 2012). The requirement for MST1/2 to activate Lats1/2 might be cell type-dependent. For instance, MST1/2 knockout in mouse livers does not significantly affect Lats1/2 phosphoryla- tion (Zhou et al. 2009), suggesting that additional ki- Figure 2. The core Hippo pathway. MST1/2 phosphorylates Sav, Lats1/2, and Mob; Lats1/2 phosphorylates YAP/TAZ; and phos- nases may regulate Lats1/2 activity. In addition to protein phorylated YAP/TAZ interacts with 14-3-3 and results in cyto- phosphorylation, the protein levels of Lats1/2 kinases are plasmic retention. Moreover, YAP/TAZ phosphorylation leads controlled by Itch E3 ubiquitin ligase-mediated degrada- to protein degradation. When dephosphorylated, YAP/TAZ enter tion (Ho et al. 2011). nuclei and induce gene transcription by interacting with tran- Lats1/2 directly interact with and phosphorylate YAP/ scription factors TEAD1–4. Drosophila orthologs for these core TAZ (Huang et al. 2005; Dong et al. 2007; Zhao et al. components are shown in brackets.

356 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

Table 1. Hippo pathway components in mammals and Drosophila Mammalian Drosophila Junctional localization interaction Core components MST1/2 Hpo (Hippo) U Sav1 Sav (Salvador) Lats1/2 Wts (Warts) U Mob1 (a and b) Mats YAP/TAZ Yki (Yorki) U TEAD1–4 Sd (Scalloped) Apical–basal polarity (TJs and AJs) Crb1–3 Crb (Crumbs) U Frmd6 (?) Ex (Expanded) UU NF2 (Mer) Mer () UU Kibra Kibra U aPKC aPKC U PAR3 Baz (Bazooka) U PAR6 Par6 U PALS1 Sdt (Stardust) U Scrib Scrib (Scribble) Dlg Dlg Lgl Lgl (Discs large) AMOT () ? UU PTPN14 Pez UU Ajuba/LIMD1/WTIP Jub UU a- a-Catenin UU b-Catenin b-Catenin U ZO-1 ZO-1 U ZO-2 ZO-2 E-cad (E-) E-cad U Planar cell polarity Fat1-4 Fat U Dchs1/2 Ds (Dachsous) UU? Fjx1 Fj (four-jointed) ? Dachs Zyxin/Lpp/Trip6 Zyx (zyxin) U Lix1, Lix1L Lft (lowfat) CK1d/e Dco (Discs overgrowth) ZDHHCs App (approximated) Other components Taok1-3 Tao U RASSF1-6 RASSF U PP2A (STRIPAK) STRIPAK (PP2A) U? PP1 PP1 U Itch Su(DX) bTRCP Slimb 14-3-3 14-3-3 U Mammalian Hippo pathway components and their Drosophila orthologs are summarized. Check marks indicate localization to tight junctions (TJs), adherens junctions (AJs), or actin cytoskeleton. Question marks indicate unsure information. by interacting with DNA-binding transcription factors. Apical–basal polarity: the polarized localization of hippo YAP/TAZ mainly bind to the transcription factors components TEAD1–4 to regulate genes involved in cell proliferation and cell death (Vassilev et al. 2001; Goulev et al. 2008; Wu Epithelial cells usually adhere to one another through et al. 2008; Zhang et al. 2008; Zhao et al. 2008). Besides cell–cell junctions such as adherens junctions (AJs), des- TEADs, YAP/TAZ may also interact with other tran- mosomes, and tight junctions (TJs). TJs and AJs, with help scription factors, such as Smad1 (Alarcon et al. 2009), from different polarity complexes, divide the plasma Smad2/3 (Varelas et al. 2008), Smad7 (Ferrigno et al. membrane into an apical domain and a basolateral domain 2002), RUNX1/2 (Yagi et al. 1999), p63/ (Strano and thereby establish an apical–basal polarity in epithelial et al. 2001), and ErbB4 (Komuro et al. 2003; Omerovic cells (Martin-Belmonte and Perez-Moreno 2012). Interest- et al. 2004); these interactions may mediate transcrip- ingly, many upstream regulators identified for the Hippo tion of diverse genes involved in proliferation, differ- pathway are known components of TJs, AJs, or apical– entiation, and development. basal polarity protein complexes (Fig. 3A).

GENES & DEVELOPMENT 357 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan

Figure 3. Regulatory mechanisms for the Hippo pathway. Regulation of the Hippo pathway by apical–basal polarity (A), PCP (B), mechanical cues and GPCR signaling (C), and actin cytoskeleton (D). Arrowed or blunted ends indicate activation or inhibition, respectively. Dashed lines indicate indirect or unknown mechanisms. Red lines in D represent actin filaments.

Mer (Merlin; also known as NF2 for neurofibromatosis- signal enhances MST1 kinase activity (Khokhlatchev et al. 2) and Ex (Expanded) are two proteins that belong to the 2002). FERM (4.1, Ezrin, Radxin, and Moesin) domain-containing Drosophila crumbs (Crb) has been identified as a cell family of proteins. Both Mer and Ex have tumor suppressor surface regulator for the Hippo pathway (Fig. 3A; CL functions and work together to regulate cell proliferation Chen et al. 2010; Grzeschik et al. 2010; Ling et al. 2010; and differentiation (McCartney et al. 2000). In Drosophila, Robinson et al. 2010). In Drosophila embryos, Crb is genetic inactivation of both Mer and Ex revealed a dra- localized at the subapical plasma membrane and plays an matic overgrowth phenotype similar to that of the Hpo important role in organizing apical–basal polarity (Tepass mutants (Hamaratoglu et al. 2006). Later, Kibra (a WW and et al. 1990). As a , Crb has a large C2 domain-containing protein) was identified to physi- extracellular domain and a short intracellular domain. cally interact with Mer and Ex, and these three proteins The short intracellular domain contains a FERM-binding activate Wts in a cooperative manner (Baumgartner et al. motif (FBM) that can interact with Ex, and this interac- 2010; Genevet et al. 2010; Yu et al. 2010). tion modulates Ex localization and stability, which in Mer, Ex, and Kibra colocalize at the apical domain of turn regulates the activity of Hippo pathway kinases and polarized epithelial cells (Fig. 3A; Boedigheimer and Yki (CL Chen et al. 2010; Ling et al. 2010; Robinson et al. Laughon 1993; Boedigheimer et al. 1997; Yu et al. 2010). 2010). The connection of Crb with Ex and core compo- Mer and Ex have been considered as a linker for the apical nents of the Hippo pathway is also reflected by an over- plasma membrane and actin cytoskeleton (Bretscher et al. growth phenotype corresponding to Crb deficiency (Ling 2002). Kibra contains a C2 domain that interacts with et al. 2010). Interestingly, overexpression of Crb leads to and may target interacting proteins to the Ex mislocalization and inactivation of the Hippo path- cell surface (Kremerskothen et al. 2003). Sav and Hpo way, likely due to a dominant-negative effect of overex- physically associate with Mer and Ex (Yu et al. 2010), and pressed Crb (CL Chen et al. 2010; Grzeschik et al. 2010; Kibra interacts with Wts (Genevet et al. 2010), suggesting Robinson et al. 2010). that the Mer/Ex/Kibra complex may recruit the Hippo Similar to the Crb complex, the Par apical complex also pathway kinases to the apical plasma membrane for acti- regulates the Hippo pathway (Fig. 3A). Overexpression of vation. Indeed, it has been shown that Mats is activated aPKC, a component of the Par complex, can induce Yki at the plasma membrane (Ho et al. 2010), and targeting activity and tissue overgrowth (Grzeschik et al. 2010; MST1 to the plasma membrane by adding a myristoylation Sun and Irvine 2011). The activity of the Par complex is

358 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation antagonized by the basal Scrib (Scribble) complex (Martin- a-Catenin is a component of AJs that functions as Belmonte and Perez-Moreno 2012). Indeed, depletion of a linker for membrane and the actin cytoskel- Scrib or Lgl also resulted in activation of Yki (Grzeschik eton (Drees et al. 2005). An inhibitory role of a-catenin et al. 2010; Menendez et al. 2010; Sun and Irvine 2011). on YAP activity has also been reported, and this in- The regulation of apical–basal polarity on the Hippo hibition of YAP may contribute to the tumor suppressor pathway is largely conserved in mammals. NF2 is an function of a-catenin (Fig. 3A; Schlegelmilch et al. 2011; extensively studied tumor suppressor, and mutations in Silvis et al. 2011). In keratinocytes, YAP strongly in- the NF2 gene cause the development of nonmalignant teracts with a-catenin, and this interaction is mediated tumors, a syndrome called neurofibromatosis type 2. by 14-3-3. Unlike AMOT, the phosphorylation of YAP at Mice with conditional NF2 knockout in the liver develop S127 is required for interaction with a-catenin because hepatocellular carcinoma, cholangiocarcinoma, and bile 14-3-3 only binds to phosphorylated YAP (Schlegelmilch duct hamartomas (Benhamouche et al. 2010; Zhang et al. et al. 2011). The trimeric complex of a-catenin, 14-3-3, 2010). NF2 patients usually develop cataracts; mice with and YAP sequesters YAP at AJs and prevents YAP de- conditional NF2 knockout in lens also develop phosphorylation/activation. In mammary epithelial Eph4 cataracts (Zhang et al. 2010). Interestingly, the cells, knockdown of a-catenin also induces YAP/TAZ of NF2 knockout in the liver and eye were largely blocked nuclear localization (Varelas et al. 2010), suggesting that by heterozygous deletion of Yap (Zhang et al. 2010). In the regulation of YAP/TAZ by a-catenin is present in addition, overexpression of NF2 in mammalian cells re- a variety of cell types. sults in Lats activation and YAP inhibition (Zhao et al. Another AJ component, protein tyrosine phosphatase 2007; Zhang et al. 2010). These results suggest that Mer is 14 (PTPN14), has also been shown to be a regulator of the also an upstream component of the mammalian Hippo Hippo pathway (JM Huang et al. 2012; Liu et al. 2012; pathway. Wang et al. 2012). PTPN14 can directly interact with Disruption of TJs or AJs in cultured mammalian cells YAP, and this interaction is mediated by PPxY motifs of (by depletion of extracellular calcium or knockdown of PTPN14 and WW domains of YAP (JM Huang et al. 2012; Crb3 or PALS1) causes induction of YAP/TAZ nuclear Liu et al. 2012; Wang et al. 2012). PTPN14 also contains localization and target (Varelas et al. an N-terminal FERM domain, and the overall domain 2010). Moreover, Scrib also positively regulates the Hippo organization is similar to that of Ex in Drosophila. pathway kinases, and down-regulation of Scrib leads to Moreover, Pez (the Drosophila ortholog of PTPN14) has YAP/TAZ activation (Cordenonsi et al. 2011; Chen et al. been shown to interact with Kibra and inactivate Yki 2012). In addition, many cell junction proteins, such as (Poernbacher et al. 2012). PTPN14–YAP interaction re- LIN7C, PATJ, MPDZ, PTPN14, angiomotin (AMOT), and sults in cytoplasmic localization of YAP and decreased a-catenin, have also been identified as interacting part- YAP activity; however, there are contradictory data on ners of core Hippo pathway components (Fig. 3A; Varelas the role of the tyrosine phosphatase activity of PTPN14 et al. 2010; Wang et al. 2011; KL Guan, unpubl.). on YAP (JM Huang et al. 2012; Liu et al. 2012; Wang et al. AMOT proteins, a family of proteins including AMOT, 2012). AMOTL1, and AMOTL2, interact extensively with mul- Several other proteins important in establishing or tiple TJ components and are important for maintaining TJ maintaining apical–basal polarity have been shown to integrity and epithelial cell polarity (Wells et al. 2006). modulate the Hippo pathway. In mammalian cells, cell Recently, an interaction between AMOT and YAP/TAZ adhesion mediated by homophilic binding of E-cadherin has been identified (Chan et al. 2011; Wang et al. 2011; led to YAP inactivation (Kim et al. 2011). Ajuba can Zhao et al. 2011). The AMOT–YAP/TAZ interaction is interact with Sav and Lats kinases in mammalian cells not dependent on the YAP/TAZ phosphorylation status and Drosophila and exhibits an inhibitory effect on and is instead mediated by AMOT PPxY motifs and YAP/ YAP/Yki (Das Thakur et al. 2010). LKB1 (liver kinase TAZ WW domains (Chan et al. 2011; Wang et al. 2011; B1) is able to induce YAP phosphorylation (Nguyen Zhao et al. 2011). AMOT proteins recruit YAP/TAZ to et al. 2012). NPHP4 (nephronophthisis 4) can interact TJs or the actin cytoskeleton, which consequently results with and inhibit Lats1 (Habbig et al. 2011). ZO-2 (zona in reduced YAP/TAZ nuclear localization and activity occludens-2) can induce YAP nuclear localization (Oka (Zhao et al. 2011). In addition, AMOT proteins also induce et al. 2010), whereas ZO-1 has been shown to repress YAP/TAZ phosphorylation at Lats target sites (Zhao et al. TAZ activation (Remue et al. 2010). These results 2011); this might be due to a scaffolding function of AMOT indicate that cell–cell contact, integrity of cell junc- on Hippo pathway components such as MST2, Lats2, and tions, and apical–basal polarity are important in regu- YAP (Paramasivam et al. 2011). AMOT proteins can lation of the Hippo pathway. Apical–basal polarity can therefore inhibit YAP/TAZ activity by both phosphoryla- regulate the Hippo pathway by either recruiting the tion-dependent and phosphorylation-independent mecha- Hippo pathway kinases to the apical domain for activa- nisms. Interestingly, AMOT has been shown to interact tion or sequestering Yki/YAP/TAZ at cell junctions with NF2 and is required for tumorigenesis caused by NF2 (Fig. 3A), both resulting in inactivation of YKi/YAP/ deficiency (Yi et al. 2011). An ortholog of AMOT in TAZ. However, it is worth noting that the cellular Drosophila has not been identified, suggesting that regu- localization of YAP is mainly in the cytoplasm and lation of AMOT on the Hippo pathway may be different nucleus (Zhao et al. 2011); the interaction between cell between Drosophila and mammals. junctional proteins and YAP/TAZ may not result in

GENES & DEVELOPMENT 359 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan a predominant localization of YAP/TAZ at the cellular and Fat4 knockout mice with abnormal PCP (Mao et al. apical domain. 2011). In , Fat1 depletion was shown to activate YAP in a Scrib-dependent manner (Skouloudaki et al. 2009). In mammals, an obvious Dachs ortholog is lacking, Planar cell polarity (PCP): coordinates for the Hippo suggesting that the connection between the Ft/Ds system pathway and the Hippo pathway may not be conserved in mam- Epithelial cells are also polarized along an axis perpen- mals. The effect of the Fzi/Fmi PCP system on the Hippo dicular to the apical–basal axis, in which clustered cells pathway is less well understood. Recently, it has been within an epithelial plate are coordinated, aligned, and shown that overexpression of Frizzled 4 can activate YAP orientated to the same direction, and this cell polarity is and that wnt signaling can activate TAZ in mammalian termed PCP (Simons and Mlodzik 2008). In addition to cells (Azzolin et al. 2012; W Huang et al. 2012; Yu et al. epithelial cells, PCP is also present in many other cell 2012b), suggesting that the Fzi/Fmi system may also types, such as mesenchymal cells, and is important in cell regulate the Hippo pathway. migration and cell interchalation (Simons and Mlodzik 2008). Two molecular networks are critical in establish- G-protein-coupled receptor (GPCR) signaling: sensing ing PCP: One is the Frizzled/Flamingo (Fzi/Fmi) system, diffusible signals and the other is the Fat/Dachsous (Ft/Ds) system (Simons and Mlodzik 2008). The Ft/Ds PCP system has been shown A large number of growth factors regulate cell prolifera- to regulate the Hippo pathway in Drosophila (Fig. 3B). tion by activating membrane receptors and intracellular Ft is a tumor suppressor and affects tissue growth signaling pathways. It is reasonable to speculate that the (Mahoney et al. 1991). Loss of Ft results in activation of YAP/TAZ oncoproteins are regulated by growth factors. Yki by inactivating either Ex or Wts (Bennett and Harvey However, several well-known growth factors, such as in- 2006; Cho et al. 2006; Silva et al. 2006; Willecke et al. sulin and EGF, have no significant effect on YAP phos- 2006; Feng and Irvine 2007; Tyler and Baker 2007). Ft phorylation (Zhao et al. 2007; Yu et al. 2012b). In mam- and Ds are both atypical cadherins, which form intercel- mals, the potential identity of extracellular ligands and lular heterodimers (Cho and Irvine 2004; Matakatsu and their cognate receptors that regulate the Hippo pathway Blair 2004), and this dimerization is regulated by Fj (four- remained elusive until recently. Two independent groups jointed)-mediated phosphorylation (Ishikawa et al. 2008). have reported that serum could rapidly activate YAP/TAZ Ds and Fj show gradient expression with opposite direc- in cultured cells. By extensive biochemical analysis, LPA tions in many tissues, and this expression pattern might and S1P were identified as the major components in be critical for Ft activity (Rogulja et al. 2008; Willecke et al. serum responsible for YAP/TAZ activation (Miller et al. 2008; Zecca and Struhl 2010). A sharp Ds gradient may 2012; Yu et al. 2012b). Both reports showed that LPA or inhibit Ft activity, which leads to localization of atypical S1P bound to their corresponding membrane GPCRs and Dachs to subapical regions (Cho et al. 2006; Feng act through Rho to activate YAP/TAZ. Consis- and Irvine 2007). Polarized Dachs promotes interaction tently, another report showed that thrombin, which acti- between Zyxin and Wts, which in turn leads to Wts deg- vates protease-activated receptors (PARs; a GPCR), also radation (Fig. 3B; Rauskolb et al. 2011). Several proteins stimulated YAP/TAZ activity via Rho GTPases (Mo et al. have been reported to modulate the inhibitory effect of Ft 2012). These results suggest that YAP/TAZ can be regu- on Yki. Dco (discs overgrown), a CK1 homolog, is able to lated by diffusible extracellular signals and cell surface phosphorylate the intracellular domain of Ft and induce Ft receptors (Fig. 3C). activity (Sopko et al. 2009). App (approximated), a palmi- Yu et al. (2012b) further showed that YAP/TAZ is toyltransferase, can relieve the Ft inhibition on Dachs and robustly regulated by many GPCRs and their cognate promote its apical localization (Matakatsu and Blair 2008). ligands and established a general function of GPCR in Lft (lowfat) can bind to Ft and Ds and thereby increases YAP/TAZ regulation. GPCRs usually activate downstream their protein stability (Mao et al. 2009). signaling through heterotrimeric G proteins. Ga12/13-, The effect of the Ft/Ds PCP system on the Hippo path- Gaq/11-, or Gai/o-coupled signals induce YAP/TAZ activ- way may be modulated by different morphogens. Dpp ity, whereas Gas-coupled signals repress YAP/TAZ activ- (decapentaplegic; a BMP homolog) and Wingless (a Wnt ity (Fig. 3C). In the latter scenario, glucagon, epinephrine, homolog) were shown to regulate the expression of Ds and a dopamine receptor agonist induce YAP/TAZ phos- and Fj (Rogulja et al. 2008; Zecca and Struhl 2010), sug- phorylation. Interestingly, in a screen for YAP inhibitors, gesting that these morphogens may help in establishing dobutamine has been shown to inhibit YAP (Bao et al. the gradient of Ds and Fj. In addition, Fj is secreted and 2011). Dobutamine is an agonist for the b1 adrenergic may function as a morphogen to regulate Ft/Ds phosphor- receptor, which likely inhibits YAP by activating Gas. ylation (Ishikawa et al. 2008; Tagliabracci et al. 2012). These results suggest that the activity of YAP/TAZ can be Our understanding of the Ft/Ds PCP system in the either up-regulated or down-regulated by GPCR signaling, mammalian Hippo pathway is limited. There are two Ds depending on which Ga protein is activated. How up- orthologs (Hchs1–2) and four Ft orthologs (Fat1–4) in stream G-protein signals are transmitted to the Hippo mammals. Among the four Fat genes in , Fat4 pathway is not fully understood, it is likely that these has the highest homology with Drosophila Ft. However, signals regulate YAP/TAZ by modulating the actin cyto- defects in YAP and Lats1 have not been observed in Dchs1 skeleton (also see below).

360 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

GPCR represents the largest family of plasma mem- (2012) also revealed that RhoA strongly enhances YAP/ brane receptors that can be activated or inactivated by TAZ activity. Moreover, Rac and Cdc42 might also a wide range of physiological ligands or pharmaceutical regulate YAP/TAZ activity, although less potently when drugs (Lappano and Maggiolini 2011). Therefore, YAP/ compared with RhoA (Zhao et al. 2012). These results are TAZ activity might be fine-tuned by multiple GPCR consistent with a general role of Rho GTPases in regulat- signals in a given cellular environment (Fig. 3C). Since ing dynamics of the actin cytoskeleton and promoting most extracellular signals identified in these studies are cell proliferation (Jaffe and Hall 2005). In addition to actin hormonal factors, it is possible that cells adjacent to cytoskeleton, microtubules have been shown to regulate blood vessels will be preferentially regulated. Interest- YAP/TAZ phosphorylation (Zhao et al. 2012), indicating ingly, YAP activation has been observed at perivascular that the Hippo pathway might be regulated by different regions (Fernandez et al. 2009). YAP/TAZ could mediate types of cellular cytoskeleton. the physiological functions of LPA or thrombin in induc- The regulation of the Hippo pathway by GPCR signal- ing gene expression, cell migration, and/or cell prolifera- ing and mechanical cues strongly suggests that the actin tion, and YAP/TAZ are activated in induced cytoskeleton may function as a mediator and integrator by transgenic expression of LPA receptor in mice (Mo of various upstream signals to the Hippo pathway. In- et al. 2012; Yu et al. 2012b). As a downstream branch of deed, two studies in Drosophila have revealed a link GPCR signaling, the Hippo pathway may mediate many between the actin cytoskeleton and the Hippo pathway biological functions of GPCRs, particularly those related (Fernandez et al. 2011; Sansores-Garcia et al. 2011). De- to cell proliferation, cell survival, and tissue growth (Yu pletion of actin-capping protein, which inhibits actin et al. 2012a; also see below). polymerization, resulted in Yki activation and tissue out- growth. Similar phenotypes were observed when Capulet (an actin-binding protein that inhibits polymerization) was (ECM) and cytoskeleton: sensing inactivated or a constitutively active Diaphanous (Dia; mechanical cues induces actin polymerization) was overexpressed. All of In vivo, cells are experiencing extensive mechanical these manipulations led to an increase in F-actin, suggest- signals from neighboring cells, the ECM, and surrounding ing that F-actin can induce Yki activity. Overexpression of biological fluids. In addition, cell shape and geometry also Wts, but not Ex or Hpo, significantly reversed the pheno- generate mechanical forces. Cells are able to sense and type of constitutively active Dia, indicating that the effect adapt to these mechanical signals and may undergo pro- of F-actin on Yki is mediated by Wts. In mice, knockout of liferation, differentiation, , and migration (Vogel destrin, which is an actin-depolymerizing factor, resulted and Sheetz 2006). The cellular cytoskeleton can respond in an abnormal actin cytoskeleton and accelerated pro- to and integrate extracellular mechanical signals. For in- liferation of corneal epithelial cells (Ikeda et al. 2003), stance, actin filaments (F-actin) have been considered as suggesting that the role of F-actin in regulating YAP/TAZ important regulators of cell proliferation (Provenzano and activity might be conserved in mammals. Keely 2011), and the dynamics of microtubules are essen- Dupont et al. (2011) also showed that YAP/TAZ could tial for (Sorger et al. 1997). Mechanotransduc- sense cellular tension. Actomyosin (composed of myosin tion is involved in not only normal physiology, but also and actin) is present in bundles in nonmuscle cells, where tumorigenesis and cancer metastasis (Huang and Ingber it can generate contraction and tension following RhoA 2005). Both microtubules and F-actin are critical for cancer activation (Clark et al. 2007). When cells were treated development and are targets of cancer therapies (Jordan with the nonmuscle myosin inhibitor blebbistatin, Rho and Wilson 1998). kinase inhibitor Y27632, or myosin light chain kinase Three recent studies have shown that YAP/TAZ is reg- inhibitor ML-7, nuclear YAP/TAZ localization was re- ulated by mechanical cues in mammalian cells (Fig. 3C; duced (Dupont et al. 2011; Wada et al. 2011). Y27632 had Dupont et al. 2011; Wada et al. 2011; Zhao et al. 2012). also been shown to block the effect of S1P on YAP/TAZ Dupont et al. (2011) and Wada et al. (2011) showed that (Miller et al. 2012). However, in other reports, these drugs YAP/TAZ was regulated by cell geometry, with active were unable to block the effect of LPA-induced, S1P- YAP/TAZ present in cells that have undergone cell spread- induced, thrombin-induced, and cell attachment-induced ing, and inactive YAP/TAZ found in round and compact YAP activity (Mo et al. 2012; Yu et al. 2012b; Zhao et al. cells. Dupont et al. (2011) also showed that YAP/TAZ 2012). These discrepancies might be due to different could respond to the stiffness of the ECM, with active YAP experimental settings, such as cell lines and conditions (YAP predominantly in the nucleus) in cells seeded on stiff of treatment. However, it is also possible that additional surfaces, and inactive YAP/TAZ in cells seeded on soft signaling pathways evoked by these mechanical or dif- surfaces. Zhao et al. (2012) demonstrated that cell de- fusible signals are involved in the regulation of YAP/TAZ tachment and attachment could either repress or induce activity (Fig. 3C). Therefore, further investigation is re- YAP/TAZ activity, respectively, and inhibition of YAP/ quired to clarify whether cellular tension is responsible TAZ was involved in cell detachment-induced anoikis (a for YAP/TAZ regulation. specific type of apoptosis). All three studies revealed that It is still unclear how the actin cytoskeleton transmits the rearrangement of actin cytoskeleton in response to upstream signals to the Hippo pathway. Both MST1/2 and different mechanical cues is associated with changes of Lats1 have been shown to bind or colocalize with F-actin YAP/TAZactivity.Dupontetal.(2011)andZhaoetal. (Densham et al. 2009; Visser-Grieve et al. 2011), suggesting

GENES & DEVELOPMENT 361 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan a model in which F-actin may directly regulate the activity 2012); in addition, these adaptor proteins may regulate of Hippo pathway kinases. In mammalian cells, the kinase activity of and PAK1-Rac, thereby modulating the activity of Lats1 and the phosphorylation status at the apical actin dynamics (Kissil et al. 2003; Perez-Moreno hydrophobic motif and activation loop of Lats1/2 are and Fuchs 2006; Wells et al. 2006). Therefore, it is pos- clearly sensitive to GPCR signaling and cell detachment; sible that the phenotypes of NF2, AMOT, a-catenin, and however, the phosphorylation and in vitro kinase activity b-catenin deficiency on Yki/YAP/TAZ activity and cell of MST1/2 are not significantly regulated by these up- proliferation are mediated by local actin rearrange- stream signals (Mo et al. 2012; Yu et al. 2012b; Zhao et al. ments. In keratinocytes and mammary epithelial cells, 2012), indicating that MST1/2 are not direct targets of calcium depletion led to disruption of cell junctions these upstream signals. On the other hand, Lats kinases and YAP/TAZ nuclear enrichment (Varelas et al. 2010; were required for YAP/TAZ regulation by GPCR signaling, Schlegelmilch et al. 2011). Calcium-chelating agents cell attachment, and cell geometry (Wada et al. 2011; Mo may regulate intracellular actin dynamics, as disruption of et al. 2012; Yu et al. 2012b; Zhao et al. 2012). Meanwhile, cell junctions by calcium depletion resulted in an increase actin cytoskeleton may also regulate YAP/TAZ phosphor- of actomyosin contraction in bovine corneal endothelial ylation via a Lats-independent mechanism (Dupont et al. cells (Ramachandran and Srinivas 2010). However, it is 2011; Miller et al. 2012). In addition, the role of F-actin in also possible that the effect of actin rearrangements on the Hippo pathway regulation might be indirect. F-actin may Hippo pathway is mediated by other cellular processes; for function as a platform and facilitate signal transmission instance, the actin cytoskeleton is required for the estab- between upstream regulators and core Hippo pathway lishment of cell polarity (Li and Gundersen 2008). components. Protein kinases or phosphatases down- Actin cytoskeleton may also mediate the effect of PCP stream from G proteins and Rho GTPases may regulate on the Hippo pathway. Dachs in the Fat/Ds system is Hippo pathway components in an actin cytoskeleton- a myosin-like protein, which may directly or indirectly dependent manner (Fig. 3C). Clearly, the mechanism affect actin dynamics (Rauskolb et al. 2011). In addition, linking F-actin to the Hippo pathway is one of the most RhoA is a well-known downstream player of the non- important questions yet to be answered in the field. canonical wnt pathway (Habas et al. 2001); thus Fzi/Fmi As mentioned above, the Hippo pathway is regulated may regulate YAP/TAZ activity via RhoA and actin organi- by apical–basal polarity in epithelial cells, PCP, mechan- zation. Collectively, actin dynamics emerges as a central ical cues, and GPCR signaling. One common feature of mediator for YAP/TAZ regulation by a wide range of these regulatory mechanisms is the involvement of actin stimuli (Fig. 3D). cytoskeleton (Fig. 3D). The integration of multiple up- stream signals to the Hippo pathway by F-actin may Regulation of the Hippo pathway: implications explain the YAP/TAZ activity regulation under diverse in physiological and pathological conditions conditions. Actin dynamics is tightly regulated by Rho GTPases when cells are experiencing mechanical forces Recently, the Hippo pathway has been shown to regulate or stimulation by extracellular ligands (Sah et al. 2000; the functions of stem cells. YAP and TAZ are required Vogel and Sheetz 2006). It is well known that some GPCR for the maintenance of mouse and embryonic ligands, such as LPA, S1P, and thrombin, also induce con- stem cell pluripotency, respectively (Varelas et al. 2008; tractive actin bundles in cells (Miller et al. 2012; Mo et al. Alarcon et al. 2009; Lian et al. 2010; Qin et al. 2012). In 2012; Yu et al. 2012b). On the other hand, some ligands for transgenic or knockout mice, elevated YAP/TAZ activity Gas-coupled receptors, such as vasopressin, dopamine, and leads to an expansion of tissue-specific stem cells and the parathyroid , have been shown to counteract the blockage of cell differentiation (Camargo et al. 2007; Cao formation of actin bundles (Ding et al. 1991; Egan et al. et al. 2008; Lee et al. 2008, 2010; Zhou et al. 2009, 2011; 1991b; Roma et al. 1998; Nguyen et al. 1999; Zhang et al. Benhamouche et al. 2010; Lu et al. 2010; Song et al. 2010; 2006). Mechanical cues such as cell spreading, cell geom- Schlegelmilch et al. 2011; Zhang et al. 2011). YAP/TAZ etry, and matrix stiffness all result in rearrangement of the are important for mesenchymal stem cell (MSC) differ- actin cytoskeleton (Dupont et al. 2011; Wada et al. 2011; entiation; knockdown of YAP/TAZ in MSCs decreases Zhao et al. 2012). In cultured osteoblasts, the cross-linked osteogenesis and increases adipogenesis (Hong et al. 2005; actin and myosin are reduced when cells are plated at high Dupont et al. 2011). In addition, YAP/TAZ have been density (Egan et al. 1991a), indicating that cellular F-actin shown to be important in myogenesis (Jeong et al. 2010; level is cell density-dependent, which may provide a mech- Watt et al. 2010; Judson et al. 2012). These results suggest anism for cell density-dependent YAP phosphorylation that the Hippo pathway plays important roles in cell (Zhao et al. 2007). differentiation (Fig. 4A). Both mechanical forces and GPCR In epithelial cells, the actin cytoskeleton is more com- ligands contribute to the cell microenvironment. Stiff plex due to polarization and cell–cell junctions. There are ECM and LPA have been shown to promote osteogenesis apical or basal actin networks, and also connected actin and inhibit adipogenesis (McBeath et al. 2004; YB Liu et al. cables that span multiple pairs of cells (Baum and Georgiou 2010). On the other hand, soft ECM and cAMP signaling 2011). Some actin bundles are linked to apical junctions via (e.g., IBMX treatment) could induce adipogenesis and re- adaptor proteins such as , NF2, and AMOT, and press osteogenesis (McBeath et al. 2004; Yang et al. 2008). these physical connections will create continuity between Cell density and serum concentration are also critical dur- actin of neighboring cells (Gjorevski et al. ing cell differentiation; for instance, myogenesis requires

362 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

Figure 4. YAP/TAZ activity under different physiological and pathological conditions. (A) YAP/TAZ activity in cell differentiation. YAP/ TAZ activity is regulated by cell density, ECM, and GPCR signaling. (B) Cells close to a wound may experience different mechanical forces and a higher concentration of GPCR ligands from blood vessels. This may induce YAP/TAZ ac- tivity and promote wound healing or tissue regeneration. (C) In a blastocyst, cells in the trophectoderm (TE) and inner cell mass (ICM) have distinct YAP localization and F-actin/ tension distribution. (D) Disruption of cellular junctions may induce mechanical stress and result in changes in cell morphology, which can enrich YAP/TAZ in nuclei under these condi- tions. Activated YAP/TAZ may promote epi- thelial–mesenchymal transition (EMT) and cell migration. Cells that have escaped from epithe- lium may also encounter more GPCR ligands. Red lines represent actin filaments. (E) Aberrant GPCR signaling may activate YAP/TAZ. Ele- vated GPCR expression or activating Ga muta- tions may induce YAP/TAZ nuclei localization and activation and result in hyperproliferation that may contribute to cancer development. YAP/TAZ localization is represented by green in B–E.

higher cell density and lower serum concentration— activity may facilitate wound healing processes (Fig. 4B). conditions that favor YAP/TAZ inactivation. Altogether, For instance, thrombin is increased during blood clot- a variety of microenvironmental signals may determine ting, a process directly associated with wounds, and cell differentiation by regulating YAP/TAZ activity. may promote wound healing by activating YAP/TAZ. The Hippo pathway is also involved in tissue regener- Moreover, LPA has been shown to facilitate wound closure ation. In the intestines of mice, YAP protein levels were in a mouse model (Balazs et al. 2001). Therefore, Hippo dramatically increased following dextran sulfate sodium pathway regulation is important for wound healing and (DSS)-induced injury, and the damaged intestinal epi- regeneration. thelium underwent regeneration; however, inactivation YAP plays important roles in early embryonic develop- of YAP severely impaired regeneration (Cai et al. 2010). ment. Systematic knockout of YAP in mice is lethal, and Furthermore, Yki is required for tissue regeneration in the embryo stops developing at embryonic day 8.5 (E8.5) Drosophila midgut and wing discs (Karpowicz et al. 2010; with defects in the yolk sac, vasculogenesis, chorioallan- Ren et al. 2010a; Shaw et al. 2010; Staley and Irvine 2010; tonic fusion, and body axis elongation (Morin-Kensicki Grusche et al. 2011; Sun and Irvine 2011). Interestingly, et al. 2006). In a normal blastocyst, YAP shows nuclear TEAD1 Y406H (tyrosine-to-histidine) mutation abolishes localization in the trophectoderm (TE) and cytoplasmic YAP–TEAD interaction (Zhao et al. 2008; L Chen et al. localization in the inner cell mass (ICM), and this distinct 2010; Li et al. 2010), and this mutation is associated with distribution of YAP is important for lineage specification Sveinsson chorioretinal atrophy (a human degeneration in the preimplantation mouse embryo (Fig. 4C; Nishioka disease with absence of retinal pigment epithelium and et al. 2009). However, the underlying mechanism for this additional retinal structures) (Jonasson et al. 2007), sug- patterned YAP localization is not clear. In blastocysts, the gesting the importance of YAP/TEAD transcriptional ac- F-actin and myosin staining is strong in TE but not de- tivity in tissue growth and homeostasis. Moreover, tissue tectable in the ICM, suggesting that contractive actin damage may result in changes of mechanical or biochem- bundles are abundant in the TE (Slager et al. 1992). The ical environments, and a local increase of YAP/TAZ distribution of F-actin is in nice correlation with YAP

GENES & DEVELOPMENT 363 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan localization in blastocysts (Fig. 4C; Nishioka et al. 2007; Zhang et al. 2011; von Gise et al. 2012). Similarly, 2009). It is possible that the actin cytoskeleton is the inactivation of upstream core components of the Hippo determinant of YAP localization in this context. The pathway leads to tumor development in mice (St John distribution of F-actin in blastocysts might be regulated et al. 1999; Lee et al. 2008, 2010; Zhou et al. 2009, 2011; by multiple means: (1) Cells in the ICM are not polarized, Lu et al. 2010; Song et al. 2010; Nishio et al. 2012). whereas cells in the TE are polarized and may have more Moreover, genetic inactivation of NF2, a well-known F-actin and tension. (2) Like in cells growing in high den- tumor suppressor that acts upstream of the Hippo path- sity, cells in the ICM contact one another in all directions way (Rouleau et al. 1993; Ruttledge et al. 1994), resulted and may have less F-actin and tension. (3) The outside in tissue overgrowth in Drosophila and in mice of the TE is exposed, and GPCRs that are expressed on (Hamaratoglu et al. 2006; Benhamouche et al. 2010; the surface might be influenced by maternal , Zhang et al. 2010), and the phenotype was blocked by whereas the access of these signals to ICM cells is down-regulation of YAP (Zhang et al. 2010). YAP and TAZ prevented by the epithelium (TE). It would be interesting induced an epithelial–mesenchymal transition (EMT), a to further investigate the relationship between F-actin phenomenon crucial for the initiation of cancer metasta- and YAP localization and the upstream cues during early sis (Overholtzer et al. 2006; Lei et al. 2008; Thiery et al. embryogenesis. 2009). The role of YAP in promoting cancer metastasis The Hippo pathway is widely recognized as a signaling has also recently been demonstrated in mice (Chen et al. pathway that regulates organ size. In Drosophila, loss- 2012; Lamar et al. 2012). In addition, TAZ has been shown of-function mutants of Hpo, Sav, Wts, and Mob all lead to sustain self-renewal and induce tumor initiation of to significant tissue outgrowth, as indicated by enlarged breast cancer stem cells (Cordenonsi et al. 2011). These eyes, wings, or other appendages (Justice et al. 1995; Xu data suggest an important function of the Hippo pathway et al. 1995; Kango-Singh et al. 2002; Tapon et al. 2002; in cancer development. Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; The connection between the Hippo pathway, mechan- Udan et al. 2003; Wu et al. 2003; Lai et al. 2005). Over- ical forces, and GPCR signaling also provides new in- expression of Yki also revealed similar tissue outgrowth sights in cancer development. Following disruption of phenotypes (Huang et al. 2005). The function of the Hippo cell–cell junctions and loss of cell polarity, cells may form pathway in organ size control is conserved in mammals. extensive focal adhesions with the ECM and thereby For instance, tissue-specific overexpression of YAP in the generate cellular tension, and these cells may further- mouse liver or heart resulted in a dramatic increase of more encounter stimulation by GPCR ligands (Fig. 4D). liver or heart size (Camargo et al. 2007; Dong et al. 2007; Activation of YAP/TAZ under these conditions may von Gise et al. 2012). Consistently, knockout of MST1/2 facilitate cell proliferation and cell migration or induce or Sav in the liver or heart also induced organ size (Zhou EMT. GPCRs are crucial players in cancer development, et al. 2009; Lee et al. 2010; Lu et al. 2010; Song et al. 2010; and dysregulated GPCR signaling has been identified in Heallen et al. 2011). Recently, a connection between the many types of human cancers (Dorsam and Gutkind Hippo pathway and the PI3K–TOR pathway has been 2007). GPCR signaling can contribute to cancer in a vari- demonstrated (Strassburger et al. 2012; Tumaneng et al. ety of ways (Fig. 4E). Increased production of some GPCR 2012b; Ye et al. 2012). This is significant because TOR ligands may promote cancer development; for instance, signaling is important in cell growth; thus, the Hippo overexpression of autotaxin (an critical for LPA pathway may control organ size in part by modulating synthesis) in mouse mammary glands has been shown to cell growth (Fig. 1; Tumaneng et al. 2012a). It is possible induce breast cancer (Liu et al. 2009). Up-regulated ex- that multiple upstream signals work together to modu- pression of GPCRs may activate intracellular signaling late the Hippo pathway to determine the final organ size. automatically, as indicated by high PAR1 expression in The mechanical forces may correlate with organ size and high-grade breast cancer patients (Hernandez et al. 2009). convey the organ size information to the Hippo pathway. Activating mutations of GPCRs have been identified in Similarly, tissue-specific GPCRs may also play a role. different type of cancers, such as the metabotropic gluta- For example, acetylcholine (a for Gaq/11-coupled mate receptor mutations in melanoma and thyroid- receptor) signaling was required for salivary organogen- stimulating hormone receptor in thyroid carcinomas esis (Knox et al. 2010). Knockout of luteinizing hormone (Paschke and Ludgate 1997; Prickett et al. 2011). Activat- receptor resulted in dramatically smaller testis (Zhang ing mutations of Ga are also present in different types of et al. 2001), indicating a possible role of GPCR signaling cancers: Gaq/11-activating mutations have been iden- in tissue growth and organ size control. tified in >80% of uveal melanomas (Van Raamsdonk Hippo pathway members have been identified in the et al. 2009, 2010); Gai2a and Gas mutations have been search for tumor suppressor genes in Drosophila. Kinases identified in ovarian and endocrine tumors (Lania et al. in the Hippo pathway are generally tumor suppressors, 2001). In addition, aberrant activity of Rho GTPases whereas Yki/YAP/TAZ have oncoprotein-like functions. and GPCR regulatory molecules, such as GPCR-related Elevated YAP or TAZ expression and nuclear localization kinases, may also contribute to cancer by regulating are frequently observed in human cancers (Zhao et al. YAP/TAZ activity (Sahai and Marshall 2002; Metaye 2007; Chan et al. 2008; Steinhardt et al. 2008; Fernandez et al. 2005). Altogether, activation of YAP/TAZ by dysreg- et al. 2009; Xu et al. 2009). YAP transgenic mice display ulated GPCR signaling may play an important role in the hyperplasia and tumors (Camargo et al. 2007; Dong et al. development of human cancers.

364 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

Concluding remarks Boedigheimer MJ, Nguyen KP, Bryant PJ. 1997. Expanded func- tions in the apical cell domain to regulate the growth rate of The Hippo pathway plays critical roles in normal phys- imaginal discs. Dev Genet 20: 103–110. iology and pathogenesis, and pharmacological interven- Boggiano JC, Vanderzalm PJ, Fehon RG. 2011. Tao-1 phosphor- tions of this pathway have diverse clinical implications; ylates Hippo/MST kinases to regulate the Hippo–Salvador– therefore, it is very important to understand how this Warts tumor suppressor pathway. Dev Cell 21: 888–895. pathway is regulated. The dynamics of the actin cyto- Bretscher A, Edwards K, Fehon RG. 2002. ERM proteins and skeleton appears to act as a focal point of different signals merlin: Integrators at the cell cortex. Nat Rev Mol Cell Biol pathways to modulate YAP/TAZ activity in either a Lats- 3: 586–599. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D. 2010. dependent or Lats-independent mechanism (Fig. 3D). The restricts the oncogenic poten- However, several critical questions regarding the regu- tial of an intestinal regeneration program. Genes Dev 24: lation of the Hippo pathway by these upstream regula- 2383–2388. tors still wait to be answered. How are these regulators, Callus BA, Verhagen AM, Vaux DL. 2006. Association of especially F-actin or cellular tension, sensed by the core mammalian sterile twenty kinases, Mst1 and Mst2, with components of the Hippo pathway? To what extent does hSalvador via C-terminal coiled-coil domains, leads to its the Hippo pathway contribute to the physiological and stabilization and phosphorylation. FEBS J 273: 4264–4276. pathological functions of these upstream regulators? Are Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch one or more of these regulators the determining factors R, Brummelkamp TR. 2007. YAP1 increases organ size and for organ size control? Answers to these challenging ques- expands undifferentiated progenitor cells. Curr Biol 17: 2054– 2060. tions will advance our understanding of the regulation and Cao X, Pfaff SL, Gage FH. 2008. YAP regulates neural progenitor function of the Hippo pathway. cell number via the TEA domain transcription factor. Genes Dev 22: 3320–3334. Acknowledgments Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg We apologize for those primary works that are not cited due to EA, Sillje HH. 2005. The Ste20-like kinase Mst2 activates the scope of this review and space constraints. We thank Drs. the human large tumor suppressor kinase Lats1. Jenna L. Jewell and Carsten G. Hansen for critical reading of this 24: 2076–2086. manuscript. Research in the laboratory of K.L.G. is supported by Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, grants from the Nationa Institutes of Health and California Hong W. 2008. A role for TAZ in migration, invasion, and Institute for Regenerative Medicine. tumorigenesis of breast cancer cells. Cancer Res 68: 2592– 2598. References Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. 2011. Hippo pathway-independent restriction of TAZ and Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas YAP by angiomotin. J Biol Chem 286: 7018–7026. A, Miller AN, Manova-Todorova K, Macias MJ, et al. 2009. Chen CL, Gajewski KM, Hamaratoglu F, Bossuyt W, Sansores- Nuclear CDKs drive Smad transcriptional activation and Garcia L, Tao C, Halder G. 2010. The apical–basal cell turnover in BMP and TGF-b pathways. Cell 139: 757–769. polarity determinant Crumbs regulates Hippo signaling in Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, Bicciato Drosophila. Proc Natl Acad Sci 107: 15810–15815. S, Cordenonsi M, Piccolo S. 2012. Role of TAZ as mediator of Chen L, Chan SW, Zhang X, Walsh M, Lim CJ, Hong W, Song H. Wnt signaling. Cell 151: 1443–1456. 2010. Structural basis of YAP recognition by TEAD4 in the Balazs L, Okolicany J, Ferrebee M, Tolley B, Tigyi G. 2001. hippo pathway. Genes Dev 24: 290–300. Topical application of the lyso- Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein phosphatidic acid promotes wound healing in vivo. Am J J, Gupta S, Liang H, Lin HK, Hung MC, et al. 2012. LIFR is Physiol Regul Integr Comp Physiol 280: R466–R472. a breast cancer metastasis suppressor upstream of the Bao Y, Nakagawa K, Yang Z, Ikeda M, Withanage K, Ishigami- Hippo–YAP pathway and a prognostic marker. Nat Med 18: Yuasa M, Okuno Y, Hata S, Nishina H, Hata Y. 2011. A cell- 1511–1517. based assay to screen stimulators of the Hippo pathway reveals Cho E, Irvine KD. 2004. Action of fat, four-jointed, dachsous and the inhibitory effect of dobutamine on the YAP-dependent dachs in distal-to-proximal wing signaling. Development gene transcription. JBiochem150: 199–208. 131: 4489–4500. Baum B, Georgiou M. 2011. Dynamics of adherens junctions in Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD. 2006. epithelial establishment, maintenance, and remodeling. JCell Delineation of a Fat tumor suppressor pathway. Nat Genet Biol 192: 907–917. 38: 1142–1150. Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. Clark K, Langeslag M, Figdor CG, van Leeuwen FN. 2007. 2010. The WW domain protein Kibra acts upstream of Hippo Myosin II and mechanotransduction: A balancing act. Trends in Drosophila. Dev Cell 18: 309–316. Cell Biol 17: 178–186. Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Giovannini M, McClatchey AI. 2010. Nf2/Merlin controls Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al. progenitor homeostasis and tumorigenesis in the liver. Genes 2011. The Hippo transducer TAZ confers - Dev 24: 1718–1730. related traits on breast cancer cells. Cell 147: 759–772. Bennett FC, Harvey KF. 2006. Fat cadherin modulates organ size Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, in Drosophila via the Salvador/Warts/Hippo signaling path- Longmore GD. 2010. Ajuba LIM proteins are negative regula- way. Curr Biol 16: 2101–2110. tors of the Hippo signaling pathway. Curr Biol 20: 657–662. Boedigheimer M, Laughon A. 1993. Expanded: A gene involved Densham RM, O’Neill E, Munro J, Konig I, Anderson K, in the control of cell proliferation in imaginal discs. De- Kolch W, Olson MF. 2009. MST kinases monitor actin velopment 118: 1291–1301. cytoskeletal integrity and signal via c-Jun N-terminal kinase

GENES & DEVELOPMENT 365 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan

stress-activated kinase to regulate p21Waf1/Cip1 stability. Habbig S, Bartram MP, Muller RU, Schwarz R, Andriopoulos N, Mol Cell Biol 29: 6380–6390. Chen S, Sagmuller JG, Hoehne M, Burst V, Liebau MC, et al. Ding GH, Franki N, Condeelis J, Hays RM. 1991. Vasopressin 2011. NPHP4, a cilia-associated protein, negatively regulates depolymerizes F-actin in toad bladder epithelial cells. Am J the Hippo pathway. J Cell Biol 193: 633–642. Physiol 260: C9–C16. Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Tao C, Jafar-Nejad H, Halder G. 2006. The tumour-suppressor Gayyed MF, Anders RA, Maitra A, Pan D. 2007. Elucidation genes NF2/Merlin and Expanded act through Hippo signalling of a universal size-control mechanism in Drosophila and to regulate cell proliferation and apoptosis. Nat Cell Biol 8: mammals. Cell 130: 1120–1133. 27–36. Dorsam RT, Gutkind JS. 2007. G-protein-coupled receptors and Hao Y, Chun A, Cheung K, Rashidi B, Yang X. 2008. Tumor cancer. Nat Rev Cancer 7: 79–94. suppressor LATS1 is a negative regulator of oncogene YAP. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. 2005. J Biol Chem 283: 5496–5509. a-Catenin is a molecular switch that binds E-cadherin– Harvey KF, Pfleger CM, Hariharan IK. 2003. The Drosophila Mst b-catenin and regulates actin-filament assembly. Cell 123: ortholog, hippo, restricts growth and cell proliferation and 903–915. promotes apoptosis. Cell 114: 457–467. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al. Johnson RL, Martin JF. 2011. Hippo pathway inhibits Wnt 2011. Role of YAP/TAZ in mechanotransduction. Nature signaling to restrain cardiomyocyte proliferation and heart 474: 179–183. size. Science 332: 458–461. Egan JJ, Gronowicz G, Rodan GA. 1991a. Cell density-dependent Hernandez NA, Correa E, Avila EP, Vela TA, Perez VM. 2009. decrease in cytoskeletal actin and myosin in cultured osteo- PAR1 is selectively over expressed in high grade breast blastic cells: Correlation with cyclic AMP changes. JCell cancer patients: A cohort study. J Transl Med 7: 47. Biochem 45: 93–100. Ho LL, Wei X, Shimizu T, Lai ZC. 2010. Mob as tumor sup- Egan JJ, Gronowicz G, Rodan GA. 1991b. Parathyroid hormone pressor is activated at the to control tissue promotes the disassembly of cytoskeletal actin and myosin growth and organ size in Drosophila. Dev Biol 337: 274–283. in cultured osteoblastic cells: Mediation by cyclic AMP. J Ho KC, Zhou Z, She YM, Chun A, Cyr TD, Yang X. 2011. Itch Cell Biochem 45: 101–111. E3 ubiquitin ligase regulates large tumor suppressor 1 Feng Y, Irvine KD. 2007. Fat and expanded act in parallel to stability. Proc Natl Acad Sci 108: 4870–4875. regulate growth through warts. Proc Natl Acad Sci 104: Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, 20362–20367. Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp Fernandez LA, Northcott PA, Dalton J, Fraga C, Ellison D, PA, et al. 2005. TAZ, a transcriptional modulator of mesen- Angers S, Taylor MD, Kenney AM. 2009. YAP1 is amplified chymal stem cell differentiation. Science 309: 1074–1078. and up-regulated in hedgehog-associated medulloblastomas Huang S, Ingber DE. 2005. Cell tension, matrix mechanics, and and mediates Sonic hedgehog-driven neural precursor pro- cancer development. Cancer Cell 8: 175–176. liferation. Genes Dev 23: 2729–2741. Huang J, Wu S, Barrera J, Matthews K, Pan D. 2005. The Hippo Fernandez BG, Gaspar P, Bras-Pereira C, Jezowska B, Rebelo SR, signaling pathway coordinately regulates cell proliferation Janody F. 2011. Actin-capping protein and the Hippo path- and apoptosis by inactivating Yorkie, the Drosophila homo- way regulate F-actin and tissue growth in Drosophila. De- log of YAP. Cell 122: 421–434. velopment 138: 2337–2346. Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Ferrigno O, Lallemand F, Verrecchia F, L’Hoste S, Camonis J, Berezov A, Zhang H, Karlan B, Greene MI, Wang Q. 2012. Atfi A, Mauviel A. 2002. Yes-associated protein (YAP65) YAP modifies cancer cell sensitivity to EGFR and survivin interacts with Smad7 and potentiates its inhibitory activity inhibitors and is negatively regulated by the non-receptor against TGF-b/Smad signaling. Oncogene 21: 4879–4884. type protein tyrosine phosphatase 14. Oncogene doi: 10.1038/ Galliot B, Ghila L. 2010. Cell plasticity in homeostasis and onc.2012.231. regeneration. Mol Reprod Dev 77: 837–855. Huang W, Lv X, Liu C, Zha Z, Zhang H, Jiang Y, Xiong Y, Lei Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. 2010. QY, Guan KL. 2012. The N-terminal phosphodegron targets Kibra is a regulator of the Salvador/Warts/Hippo signaling TAZ/WWTR1 for SCFb–TrCP dependent degradation in re- network. Dev Cell 18: 300–308. sponse to PI3K inhibition. J Biol Chem 287: 26245–26253. Gjorevski N, Boghaert E, Nelson CM. 2012. Regulation of Ikeda S, Cunningham LA, Boggess D, Hawes N, Hobson CD, epithelial–mesenchymal transition by transmission of me- Sundberg JP, Naggert JK, Smith RS, Nishina PM. 2003. chanical stress through epithelial tissues. Cancer Microen- Aberrant actin cytoskeleton leads to accelerated prolifera- viron 5: 29–38. tion of corneal epithelial cells in mice deficient for destrin Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, (actin depolymerizing factor). Hum Mol Genet 12: 1029– Zider A. 2008. SCALLOPED interacts with YORKIE, the 1037. nuclear effector of the hippo tumor-suppressor pathway in Ikeda M, Kawata A, Nishikawa M, Tateishi Y, Yamaguchi M, Drosophila. Curr Biol 18: 435–441. Nakagawa K, Hirabayashi S, Bao Y, Hidaka S, Hirata Y, et al. Grusche FA, Degoutin JL, Richardson HE, Harvey KF. 2011. The 2009. Hippo pathway-dependent and -independent roles of Salvador/Warts/Hippo pathway controls regenerative tissue RASSF6. Sci Signal 2: ra59. growth in . Dev Biol 350: 255–266. Ishikawa HO, Takeuchi H, Haltiwanger RS, Irvine KD. 2008. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson Four-jointed is a Golgi kinase that phosphorylates a subset of HE. 2010. Lgl, aPKC, and Crumbs regulate the Salvador/ cadherin domains. Science 321: 401–404. Warts/Hippo pathway through two distinct mechanisms. Jaffe AB, Hall A. 2005. Rho GTPases: Biochemistry and biology. Curr Biol 20: 573–581. Annu Rev Cell Dev Biol 21: 247–269. Habas R, Kato Y, He X. 2001. Wnt/Frizzled activation of Rho Jeong H, Bae S, An SY, Byun MR, Hwang JH, Yaffe MB, Hong JH, regulates gastrulation and requires a novel Formin Hwang ES. 2010. TAZ as a novel enhancer of MyoD-mediated homology protein Daam1. Cell 107: 843–854. myogenic differentiation. FASEB J 24: 3310–3320.

366 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

Jia J, Zhang W, Wang B, Trinko R, Jiang J. 2003. The Drosophila Lappano R, Maggiolini M. 2011. -coupled receptors: Ste20 family kinase dMST functions as a tumor suppressor Novel targets for drug discovery in cancer. Nat Rev Drug by restricting cell proliferation and promoting apoptosis. Discov 10: 47–60. Genes Dev 17: 2514–2519. Lee JH, Kim TS, Yang TH, Koo BK, Oh SP, Lee KP, Oh HJ, Lee Jonasson F, Hardarson S, Olafsson BM, Klintworth GK. 2007. SH, Kong YY, Kim JM, et al. 2008. A crucial role of WW45 in Sveinsson chorioretinal atrophy/helicoid peripapillary cho- developing epithelial tissues in the mouse. EMBO J 27: 1231– rioretinal degeneration: First histopathology report. Oph- 1242. thalmology 114: 1541–1546. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC, Jordan MA, Wilson L. 1998. Microtubules and actin filaments: Jeong WI, Calvisi DF, Kim JM, et al. 2010. The Hippo– Dynamic targets for cancer chemotherapy. Curr Opin Cell Salvador pathway restrains hepatic oval cell proliferation, Biol 10: 123–130. liver size, and liver tumorigenesis. Proc Natl Acad Sci 107: Judson RN, Tremblay AM, Knopp P, White RB, Urcia R, Bari 8248–8253. CD, Zammit PS, Camargo FD, Wackerhage H. 2012. The Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Hippo pathway member Yap plays a key role in influencing Y, Guan KL. 2008. TAZ promotes cell proliferation and fate decisions in muscle satellite cells. JCellScidoi: 10.1242/ epithelial–mesenchymal transition and is inhibited by the jcs.109546. hippo pathway. Mol Cell Biol 28: 2426–2436. Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. 1995. The Li R, Gundersen GG. 2008. Beyond polymer polarity: How the Drosophila warts encodes a homolog cytoskeleton builds a polarized cell. Nat Rev Mol Cell Biol 9: of human myotonic dystrophy kinase and is required for the 860–873. control of cell shape and proliferation. Genes Dev 9: 534– Li Z, Zhao B, Wang P, Chen F, Dong Z, Yang H, Guan KL, Xu Y. 546. 2010. Structural insights into the YAP and TEAD complex. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz Genes Dev 24: 235–240. M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, et al. 2000. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, TAZ: A novel transcriptional co-activator regulated by in- Israel MA, Goldstein LS, Abujarour R, et al. 2010. The role of teractions with 14-3-3 and PDZ domain proteins. EMBO J 19: YAP transcription coactivator in regulating stem cell self- 6778–6791. renewal and differentiation. Genes Dev 24: 1106–1118. Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Ling C, Zheng Y, Yin F, Yu J, Huang J, Hong Y, Wu S, Pan D. Bellen HJ, Halder G. 2002. Shar-pei mediates cell prolifera- 2010. The apical transmembrane protein Crumbs func- tion arrest during imaginal disc growth in Drosophila. De- tions as a tumor suppressor that regulates Hippo signaling velopment 129: 5719–5730. by binding to Expanded. Proc Natl Acad Sci 107: 10532– Karpowicz P, Perez J, Perrimon N. 2010. The Hippo tumor 10537. suppressor pathway regulates intestinal stem cell regenera- Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, tion. Development 137: 4135–4145. Stephens LC, Cui X, Murrow G, et al. 2009. Expression of Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, autotaxin and lysophosphatidic acid receptors increases mam- Zhang XF, Seed B, Avruch J. 2002. Identification of a novel mary tumorigenesis, invasion, and metastases. Cancer Cell Ras-regulated proapoptotic pathway. Curr Biol 12: 253–265. 15: 539–550. Kim NG, Koh E, Chen X, Gumbiner BM. 2011. E-cadherin Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, mediates contact inhibition of proliferation through Hippo Chan SW, Lim CJ, Hong W, et al. 2010. The hippo tumor signaling-pathway components. Proc Natl Acad Sci 108: pathway promotes TAZ degradation by phosphorylating 11930–11935. a phosphodegron and recruiting the SCFb–TrCP E3 ligase. Kissil JL, Wilker EW, Johnson KC, Eckman MS, Yaffe MB, Jacks JBiolChem285: 37159–37169. T. 2003. Merlin, the product of the Nf2 tumor suppressor Liu YB, Kharode Y, Bodine PV, Yaworsky PJ, Robinson JA, gene, is an inhibitor of the -activated kinase, Pak1. Mol Billiard J. 2010. LPA induces osteoblast differentiation through Cell 12: 841–849. interplay of two receptors: LPA1 and LPA4. JCellBiochem Knox SM, Lombaert IM, Reed X, Vitale-Cross L, Gutkind JS, 109: 794–800. Hoffman MP. 2010. Parasympathetic innervation maintains Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, Gelman IH, epithelial progenitor cells during salivary organogenesis. Zhang J. 2012. PTPN14 interacts with and negatively regu- Science 329: 1645–1647. lates the oncogenic function of YAP. Oncogene doi: 10.1038/ Komuro A, Nagai M, Navin NE, Sudol M. 2003. WW domain- onc.2012.147. containing protein YAP associates with ErbB-4 and acts as Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, a co-transcriptional activator for the carboxyl-terminal frag- Finegold MJ, Lee JS, et al. 2010. Hippo signaling is a potent in ment of ErbB-4 that translocates to the nucleus. J Biol Chem vivo growth and tumor suppressor pathway in the mamma- 278: 33334–33341. lian liver. Proc Natl Acad Sci 107: 1437–1442. Kremerskothen J, Plaas C, Buther K, Finger I, Veltel S, Matanis Mahoney PA, Weber U, Onofrechuk P, Biessmann H, Bryant PJ, T, Liedtke T, Barnekow A. 2003. Characterization of KIBRA, Goodman CS. 1991. The fat tumor suppressor gene in a novel WW domain-containing protein. Biochem Biophys Drosophila encodes a novel member of the cadherin gene Res Commun 300: 862–867. superfamily. Cell 67: 853–868. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Mao Y, Kucuk B, Irvine KD. 2009. Drosophila lowfat, a novel Ho LL, Li Y. 2005. Control of cell proliferation and apoptosis modulator of Fat signaling. Development 136: 3223–3233. by mob as tumor suppressor, mats. Cell 120: 675–685. Mao Y, Mulvaney J, Zakaria S, Yu T, Morgan KM, Allen S, Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. Basson MA, Francis-West P, Irvine KD. 2011. Characteriza- 2012. The Hippo pathway target, YAP, promotes metastasis tion of a Dchs1 mutant mouse reveals requirements for through its TEAD-interaction domain. Proc Natl Acad Sci Dchs1–Fat4 signaling during mammalian development. De- 109: E2441–E2450. velopment 138: 947–957. Lania A, Mantovani G, Spada A. 2001. G protein mutations in Martin-Belmonte F, Perez-Moreno M. 2012. Epithelial cell polar- endocrine diseases. Eur J Endocrinol 145: 543–559. ity, stem cells and cancer. Nat Rev Cancer 12: 23–38.

GENES & DEVELOPMENT 367 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan

Matakatsu H, Blair SS. 2004. Interactions between Fat and of YAP, a candidate oncogene on the 11q22 Dachsous and the regulation of planar cell polarity in the amplicon. Proc Natl Acad Sci 103: 12405–12410. Drosophila wing. Development 131: 3785–3794. Pan D. 2010. The hippo signaling pathway in development and Matakatsu H, Blair SS. 2008. The DHHC palmitoyltransferase cancer. Dev Cell 19: 491–505. approximated regulates Fat signaling and Dachs localization Pantalacci S, Tapon N, Leopold P. 2003. The Salvador partner and activity. Curr Biol 18: 1390–1395. Hippo promotes apoptosis and cell-cycle exit in Drosophila. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Nat Cell Biol 5: 921–927. 2004. Cell shape, cytoskeletal tension, and RhoA regulate Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, stem cell lineage commitment. Dev Cell 6: 483–495. McCollum D. 2011. Angiomotin family proteins are novel McCartney BM, Kulikauskas RM, LaJeunesse DR, Fehon RG. activators of the LATS2 kinase tumor suppressor. Mol Biol 2000. The neurofibromatosis-2 homologue, Merlin, and the Cell 22: 3725–3733. tumor suppressor expanded function together in Drosophila Paschke R, Ludgate M. 1997. The thyrotropin receptor in to regulate cell proliferation and differentiation. Develop- thyroid diseases. N Engl J Med 337: 1675–1681. ment 127: 1315–1324. Pellettieri J, Sanchez Alvarado A. 2007. Cell turnover and adult Menendez J, Perez-Garijo A, Calleja M, Morata G. 2010. A tissue homeostasis: From to planarians. Annu Rev tumor-suppressing mechanism in Drosophila involving cell Genet 41: 83–105. competition and the Hippo pathway. Proc Natl Acad Sci 107: Perez-Moreno M, Fuchs E. 2006. Catenins: Keeping cells from 14651–14656. getting their signals crossed. Dev Cell 11: 601–612. Metaye T, Gibelin H, Perdrisot R, Kraimps JL. 2005. Pathophys- Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker iological roles of G-protein-coupled receptor kinases. Cell H. 2012. Drosophila Pez acts in Hippo signaling to restrict Signal 17: 917–928. intestinal stem cell proliferation. Curr Biol 22: 389–396. Miller E, Yang J, Deran M, Wu C, Su AI, Bonamy GM, Liu J, Polesello C, Huelsmann S, Brown NH, Tapon N. 2006. The Peters EC, Wu X. 2012. Identification of serum-derived Drosophila RASSF homolog antagonizes the hippo pathway. sphingosine-1-phosphate as a small molecule regulator of Curr Biol 16: 2459–2465. YAP. Chem Biol 19: 955–962. Poon CL, Lin JI, Zhang X, Harvey KF. 2011. The sterile 20-like Mo JS, Yu FX, Gong R, Brown JH, Guan KL. 2012. Regulation of kinase Tao-1 controls tissue growth by regulating the Salvador- the Hippo–YAP pathway by protease-activated receptors Warts-Hippo pathway. Dev Cell 21: 896–906. (PARs). Genes Dev 26: 2138–2143. Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J. 2004. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed Regulation of the MST1 kinase by autophosphorylation, by J, Alb JG, Magnuson TR, O’Neal W, Milgram SL. 2006. the growth inhibitory proteins, RASSF1 and NORE1, and by Defects in yolk sac vasculogenesis, chorioallantoic fusion, Ras. Biochem J 381: 453–462. and embryonic axis elongation in mice with targeted disrup- Praskova M, Xia F, Avruch J. 2008. MOBKL1A/MOBKL1B tion of Yap65. Mol Cell Biol 26: 77–87. phosphorylation by MST1 and MST2 inhibits cell prolifera- Nguyen B, Carbajal ME, Vitale ML. 1999. Intracellular mecha- tion. Curr Biol 18: 311–321. nisms involved in dopamine-induced actin cytoskeleton or- Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, ganization and maintenance of a round phenotype in cultured Gartner J, Jiang J, Cherukuri PF, Molinolo A, et al. 2011. rat lactotrope cells. Endocrinology 140: 3467–3477. Exon capture analysis of G protein-coupled receptors iden- Nguyen HB, Babcock JT, Wells CD, Quilliam LA. 2012. LKB1 tifies activating mutations in GRM3 in melanoma. Nat tumor suppressor regulates AMP kinase/mTOR-independent Genet 43: 1119–1126. cell growth and proliferation via the phosphorylation of Yap. Provenzano PP, Keely PJ. 2011. Mechanical signaling through Oncogene doi: 10.1038/onc.2012.431. the cytoskeleton regulates cell proliferation by coordinated Nishio M, Hamada K, Kawahara K, Sasaki M, Noguchi F, Chiba and Rho GTPase signaling. J Cell Sci 124: S, Mizuno K, Suzuki SO, Dong Y, Tokuda M, et al. 2012. 1195–1205. Cancer susceptibility and embryonic lethality in Mob1a/1b Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi Z, Yu J, Yeh RF, double-mutant mice. J Clin Invest 122: 4505–4518. Hebrok M, Ramalho-Santos M. 2012. Transcriptional analy- Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, sis of pluripotency reveals the Hippo pathway as a barrier to Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, et al. reprogramming. Hum Mol Genet 21: 2054–2067. 2009. The Hippo signaling pathway components Lats and Ramachandran C, Srinivas SP. 2010. Formation and disassembly Yap pattern Tead4 activity to distinguish mouse trophecto- of adherens and tight junctions in the corneal endothelium: derm from inner cell mass. Dev Cell 16: 398–410. Regulation by actomyosin contraction. Invest Ophthalmol Oh H, Irvine KD. 2008. In vivo regulation of Yorkie phosphor- Vis Sci 51: 2139–2148. ylation and localization. Development 135: 1081–1088. Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. 2011. Zyxin links Oka T, Mazack V, Sudol M. 2008. Mst2 and Lats kinases fat signaling to the hippo pathway. PLoS Biol 9: e1000624. regulate apoptotic function of Yes kinase-associated protein Remue E, Meerschaert K, Oka T, Boucherie C, Vandekerckhove (YAP). J Biol Chem 283: 27534–27546. J, Sudol M, Gettemans J. 2010. TAZ interacts with zonula Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller occludens-1 and -2 proteins in a PDZ-1 dependent manner. D, Bader GD, Sidhu SS, Vandekerckhove J, Gettemans J, FEBS Lett 584: 4175–4180. et al. 2010. Functional complexes between YAP2 and ZO-2 Ren F, Wang B, Yue T, Yun EY, Ip YT, Jiang J. 2010a. Hippo are PDZ domain-dependent, and regulate YAP2 nuclear signaling regulates Drosophila intestine stem cell prolifera- localization and signalling. Biochem J 432: 461–472. tion through multiple pathways. Proc Natl Acad Sci 107: Omerovic J, Puggioni EM, Napoletano S, Visco V, Fraioli R, Frati 21064–21069. L, Gulino A, Alimandi M. 2004. Ligand-regulated association Ren F, Zhang L, Jiang J. 2010b. Hippo signaling regulates Yorkie of ErbB-4 to the transcriptional co-activator YAP65 controls nuclear localization and activity through 14-3-3 dependent transcription at the nuclear level. Exp Cell Res 294: 469–479. and independent mechanisms. Dev Biol 337: 303–312. OverholtzerM,ZhangJ,SmolenGA,MuirB,LiW,SgroiDC, Ribeiro PS, Josue F, Wepf A, Wehr MC, Rinner O, Kelly G, Tapon Deng CX, Brugge JS, Haber DA. 2006. Transforming properties N, Gstaiger M. 2010. Combined functional genomic and

368 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

proteomic approaches identify a PP2A complex as a negative 2009. Phosphorylation of the tumor suppressor fat is regu- regulator of Hippo signaling. Mol Cell 39: 521–534. lated by its ligand Dachsous and the kinase discs overgrown. Robinson BS, Huang J, Hong Y, Moberg KH. 2010. Crumbs Curr Biol 19: 1112–1117. regulates Salvador/Warts/Hippo signaling in Drosophila via Sorger PK, Dobles M, Tournebize R, Hyman AA. 1997. Coupling the FERM-domain protein Expanded. Curr Biol 20: 582–590. cell division and cell death to microtubule dynamics. Curr Rogulja D, Rauskolb C, Irvine KD. 2008. Morphogen control of Opin Cell Biol 9: 807–814. wing growth through the Fat signaling pathway. Dev Cell 15: Staley BK, Irvine KD. 2010. Warts and Yorkie mediate intestinal 309–321. regeneration by influencing stem cell proliferation. Curr Biol Roma MG, Stone V, Shaw R, Coleman R. 1998. Vasopressin- 20: 1580–1587. induced disruption of actin cytoskeletal organization and Staley BK, Irvine KD. 2012. Hippo signaling in Drosophila: canalicular function in isolated rat hepatocyte couplets: Recent advances and insights. Dev Dyn 241: 3–15. Possible involvement of C. Hepatology 28: Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, 1031–1041. Montgomery EA, Anders RA. 2008. Expression of Yes-asso- Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, ciated protein in common solid tumors. Hum Pathol 39: Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, 1582–1589. Plougastel B, et al. 1993. Alteration in a new gene encoding St. John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, a putative membrane-organizing protein causes neuro- Brownstein DG, Parlow AF, McGrath J, Xu T. 1999. Mice fibromatosis type 2. Nature 363: 515–521. deficient of Lats1 develop soft-tissue sarcomas, ovarian Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, tumours and pituitary dysfunction. Nat Genet 21: 182–186. Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A, et al. 1994. Evidence for the complete inactivation of the Oren M, Sudol M, Cesareni G, Blandino G. 2001. Physical NF2 gene in the majority of sporadic meningiomas. Nat Genet interaction with Yes-associated protein enhances p73 tran- 6: 180–184. scriptional activity. J Biol Chem 276: 15164–15173. Sah VP, Seasholtz TM, Sagi SA, Brown JH. 2000. The role of Rho Strassburger K, Tiebe M, Pinna F, Breuhahn K, Teleman AA. in G protein-coupled receptor . Annu Rev 2012. Insulin/IGF signaling drives cell proliferation in part Pharmacol Toxicol 40: 459–489. via Yorkie/YAP. Dev Biol 367: 187–196. Sahai E, Marshall CJ. 2002. RHO-GTPases and cancer. Nat Rev Sun G, Irvine KD. 2011. Regulation of Hippo signaling by Jun Cancer 2: 133–142. kinase signaling during compensatory cell proliferation and Sansores-Garcia L, Bossuyt W, Wada K, Yonemura S, Tao C, regeneration, and in neoplastic tumors. Dev Biol 350: 139– Sasaki H, Halder G. 2011. Modulating F-actin organization 151. induces organ growth by affecting the Hippo pathway. Tagliabracci VS, Engel JL, Wen J, Wiley SE, Worby CA, Kinch EMBO J 30: 2325–2335. LN, Xiao J, Grishin NV, Dixon JE. 2012. Secreted kinase Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, phosphorylates extracellular proteins that regulate biomin- Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp eralization. Science 336: 1150–1153. TR, et al. 2011. Yap1 acts downstream of a-catenin to control Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber epidermal proliferation. Cell 144: 782–795. DA, Hariharan IK. 2002. salvador promotes both cell cycle Shaw RL, Kohlmaier A, Polesello C, Veelken C, Edgar BA, Tapon exit and apoptosis in Drosophila and is mutated in human N. 2010. The Hippo pathway regulates intestinal stem cell cancer cell lines. Cell 110: 467–478. proliferation during Drosophila adult midgut regeneration. Tepass U, Theres C, Knust E. 1990. crumbs encodes an EGF-like Development 137: 4147–4158. protein expressed on apical membranes of Drosophila epi- Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. 2006. The thelial cells and required for organization of epithelia. Cell tumor-suppressor gene fat controls tissue growth upstream 61: 787–799. of expanded in the hippo signaling pathway. Curr Biol 16: Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial– 2081–2089. mesenchymal transitions in development and disease. Cell Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, 139: 871–890. Camargo FD, Lantz DM, Seykora JT, Vasioukhin V. 2011. Tumaneng K, Russell RC, Guan KL. 2012a. Organ size control a-Catenin is a tumor suppressor that controls cell accumu- by Hippo and TOR pathways. Curr Biol 22: R368–R379. lation by regulating the localization and activity of the Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet transcriptional coactivator Yap1. Sci Signal 4: ra33. H, Mahadevan N, Fitamant J, Bardeesy N, Camargo FD, Simons M, Mlodzik M. 2008. Planar cell polarity signaling: Guan KL. 2012b. YAP mediates crosstalk between the Hippo From fly development to human disease. Annu Rev Genet and PI(3)K–TOR pathways by suppressing PTEN via miR-29. 42: 517–540. Nat Cell Biol 14: 1322–1329. Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, Tyler DM, Baker NE. 2007. Expanded and fat regulate growth Hartleben B, Engel C, Moeller MJ, Englert C, Bollig F, et al. and differentiation in the Drosophila eye through multiple 2009. Scribble participates in Hippo signaling and is required signaling pathways. Dev Biol 305: 187–201. for normal zebrafish pronephros development. Proc Natl Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. 2003. Hippo Acad Sci 106: 8579–8584. promotes proliferation arrest and apoptosis in the Salvador/ Slager HG, Good MJ, Schaart G, Groenewoud JS, Mummery CL. Warts pathway. Nat Cell Biol 5: 914–920. 1992. Organization of non-muscle myosin during early mu- Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, rine embryonic differentiation. Differentiation 50: 47–56. O’Brien JM, Simpson EM, Barsh GS, Bastian BC. 2009. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park Frequent somatic mutations of GNAQ in uveal melanoma O, Chang J, Simpson RM, et al. 2010. Mammalian Mst1 and and blue naevi. Nature 457: 599–602. Mst2 kinases play essential roles in organ size control and Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, tumor suppression. Proc Natl Acad Sci 107: 1431–1436. Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green Sopko R, Silva E, Clayton L, Gardano L, Barrios-Rodiles M, G, Bouvier N, et al. 2010. Mutations in GNA11 in uveal Wrana J, Varelas X, Arbouzova NI, Shaw S, Saburi S, et al. melanoma. N Engl J Med 363: 2191–2199.

GENES & DEVELOPMENT 369 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Yu and Guan

Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, Lowe SW, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. TAZ Poon RT, Luk JM. 2009. Yes-associated protein is an in- controls Smad nucleocytoplasmic shuttling and regulates dependent prognostic marker in hepatocellular carcinoma. human embryonic stem-cell self-renewal. Nat Cell Biol 10: Cancer 115: 4576–4585. 837–848. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. 1999. A WW Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, domain-containing yes-associated protein (YAP) is a novel Cockburn K, Larsen BG, Rossant J, Wrana JL. 2010. The transcriptional co-activator. EMBO J 18: 2551–2562. Crumbs complex couples cell density sensing to Hippo- Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ, Hung SC. dependent control of the TGF-b–SMAD pathway. Dev Cell 2008. cAMP/PKA regulates osteogenesis, adipogenesis and 19: 831–844. ratio of RANKL/OPG mRNA expression in mesenchymal Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. 2001. stem cells by suppressing leptin. PLoS One 3: e1540. TEAD/TEF transcription factors utilize the activation do- Ye X, Deng Y, Lai ZC. 2012. Akt is negatively regulated by main of YAP65, a Src/Yes-associated protein localized in the Hippo signaling for growth inhibition in Drosophila. Dev cytoplasm. Genes Dev 15: 1229–1241. Biol 369: 115–123. Visser-Grieve S, Zhou Z, She YM, Huang H, Cyr TD, Xu T, Yang Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, X. 2011. LATS1 tumor suppressor is a novel actin-binding Christian N, Persson NL, Shimono A, Speicher DW, protein and negative regulator of actin polymerization. Cell Marmorstein R, et al. 2011. A -associated Res 21: 1513–1516. Merlin–angiomotin complex mediates Merlin’s regulation Vogel V, Sheetz M. 2006. Local force and geometry sensing of mitogenic signaling and tumor suppressive functions. regulate cell functions. Nat Rev Mol Cell Biol 7: 265–275. Cancer Cell 19: 527–540. von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D. 2010. Kibra JN, Ma Q, Ishiwata T, Zhou B, Camargo FD, et al. 2012. functions as a tumor suppressor protein that regulates Hippo YAP1, the nuclear target of Hippo signaling, stimulates heart signaling in conjunction with Merlin and Expanded. Dev growth through cardiomyocyte proliferation but not hyper- Cell 18: 288–299. trophy. Proc Natl Acad Sci 109: 2394–2399. Yu FX, Mo JS, Guan KL. 2012a. Upstream regulators of the Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. 2011. Hippo Hippo pathway. Cell Cycle 11: 4097–4098. pathway regulation by cell morphology and stress fibers. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao Development 138: 3907–3914. J, Yuan H, Tumaneng K, Li H, et al. 2012b. Regulation of the Wang W, Huang J, Chen J. 2011. Angiomotin-like proteins Hippo–YAP pathway by G-protein-coupled receptor signal- associate with and negatively regulate YAP1. J Biol Chem ing. Cell 150: 780–791. 286: 4364–4370. Zecca M, Struhl G. 2010. A feed-forward circuit linking wing- Wang W, Huang J, Wang X, Yuan J, Li X, Feng L, Park JI, Chen J. less, fat–dachsous signaling, and the warts–hippo pathway to 2012. PTPN14 is required for the density-dependent control Drosophila wing growth. PLoS Biol 8: e1000386. of YAP1. Genes Dev 26: 1959–1971. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. 2001. Normal Watt KI, Judson R, Medlow P, Reid K, Kurth TB, Burniston JG, prenatal but arrested postnatal sexual development of lutein- Ratkevicius A, De Bari C, Wackerhage H. 2010. Yap is a novel izing hormone receptor knockout (LuRKO) mice. Mol Endo- regulator of C2C12 myogenesis. Biochem Biophys Res Com- crinol 15: 172–183. mun 393: 619–624. Zhang J, Ryder KD, Bethel JA, Ramirez R, Duncan RL. 2006. Wehr MC, Holder MV, Gailite I, Saunders RE, Maile TM, PTH-induced actin depolymerization increases mechanosen- Ciirdaeva E, Instrell R, Jiang M, Howell M, Rossner MJ, sitive channel activity to enhance mechanically stimulated et al. 2012. Salt-inducible kinases regulate growth through Ca2+ signaling in osteoblasts. J Bone Miner Res 21: 1729– the Hippo signalling pathway in Drosophila. Nat Cell Biol 1737. (in press). doi: 10.1038/ncb2658. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. 2008. The Wells CD, Fawcett JP, Traweger A, Yamanaka Y, Goudreault M, TEAD/TEF family of transcription factor Scalloped mediates Elder K, Kulkarni S, Gish G, Virag C, Lim C, et al. 2006. Hippo signaling in organ size control. Dev Cell 14: 377–387. A Rich1/Amot complex regulates the Cdc42 GTPase and Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini apical-polarity proteins in epithelial cells. Cell 125: 535–548. M, Liu P, Anders RA, Pan D. 2010. The Merlin/NF2 tumor Willecke M, Hamaratoglu F, Kango-Singh M, Udan R, Chen CL, suppressor functions through the YAP oncoprotein to regu- Tao C, Zhang X, Halder G. 2006. The fat cadherin acts late tissue homeostasis in mammals. Dev Cell 19: 27–38. through the hippo tumor-suppressor pathway to regulate Zhang H, Pasolli HA, Fuchs E. 2011. Yes-associated protein tissue size. Curr Biol 16: 2090–2100. (YAP) transcriptional coactivator functions in balancing Willecke M, Hamaratoglu F, Sansores-Garcia L, Tao C, Halder growth and differentiation in . Proc Natl Acad Sci 108: G. 2008. Boundaries of Dachsous cadherin activity modulate 2270–2275. the Hippo signaling pathway to induce cell proliferation. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Proc Natl Acad Sci 105: 14897–14902. Yu J, Li L, et al. 2007. Inactivation of YAP oncoprotein by the Wu S, Huang J, Dong J, Pan D. 2003. hippo encodes a Ste-20 Hippo pathway is involved in cell contact inhibition and family protein kinase that restricts cell proliferation and tissue growth control. Genes Dev 21: 2747–2761. promotes apoptosis in conjunction with salvador and warts. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Cell 114: 445–456. Chinnaiyan AM, et al. 2008. TEAD mediates YAP-dependent Wu S, Liu Y, Zheng Y, Dong J, Pan D. 2008. The TEAD/TEF gene induction and growth control. Genes Dev 22: 1962–1971. family protein Scalloped mediates transcriptional output of Zhao B, Li L, Lei Q, Guan KL. 2010a. The Hippo–YAP pathway the Hippo growth-regulatory pathway. Dev Cell 14: 388–398. in organ size control and tumorigenesis: An updated version. Xu T, Wang W, Zhang S, Stewart RA, Yu W. 1995. Identifying Genes Dev 24: 862–874. tumor suppressors in genetic mosaics: The Drosophila lats Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. 2010b. A co- gene encodes a putative protein kinase. Development 121: ordinated phosphorylation by Lats and CK1 regulates YAP 1053–1063. stability through SCF(b-TRCP). Genes Dev 24: 72–85.

370 GENES & DEVELOPMENT Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

Hippo pathway regulation

Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL. 2011. Angiomotin is a novel Hippo pathway component that in- hibits YAP oncoprotein. Genes Dev 25: 51–63. Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. 2012. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26: 54–68. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, et al. 2009. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16: 425–438. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, et al. 2011. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci 108: E1312–E1320.

GENES & DEVELOPMENT 371 Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press

The Hippo pathway: regulators and regulations

Fa-Xing Yu and Kun-Liang Guan

Genes Dev. 2013, 27: Access the most recent version at doi:10.1101/gad.210773.112

References This article cites 205 articles, 75 of which can be accessed free at: http://genesdev.cshlp.org/content/27/4/355.full.html#ref-list-1

License

Email Alerting Receive free email alerts when new articles cite this article - sign up in the box at the top Service right corner of the article or click here.

Copyright © 2013 by Cold Spring Harbor Laboratory Press